Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/24737
Title: | Improved Respiratory Outcomes for X-Linked Myotubular Myopathy (XLMTM) with Gene Replacement Therapy, Resamirigene Bilparvovec (ASPIRO): Preliminary Results from ASPIRO, a Phase 1/2/3 Study |
Authors: | Perez, GF Shieh, P Kuntz, N Dowling, J Mueller-Felber, W Blaschek, A Bonnemann, C Foley, A Saade, D Seferian, A Servais, L Lawlor, M MacBean, V Coats, J Han, C Lee, J Noursalehi, M Prasad, S Rico, S Miller, W Graham, R |
Issue Date: | 1-May-2022 |
Publisher: | American Thoracic Society |
Citation: | Perez, G.F. et al. (2022) 'Improved Respiratory Outcomes for X-Linked Myotubular Myopathy (XLMTM) with Gene Replacement Therapy, Resamirigene Bilparvovec (ASPIRO): Preliminary Results from ASPIRO, a Phase 1/2/3 Study', American Journal of Respiratory and Critical Care Medicine, 205, A3003, pp. 1-3. doi: 10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3003. |
URI: | https://bura.brunel.ac.uk/handle/2438/24737 |
DOI: | https://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3003 |
ISSN: | 1073-449X |
Other Identifiers: | A3003 |
Appears in Collections: | Dept of Health Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
MeetingAbstract.pdf | 129.71 kB | Adobe PDF | View/Open |
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.